Pricing Log in Create free account

Eupraxia Pharmaceuticals Inc. (EPRX) vs Shattuck Labs, Inc. (STTK)

Eupraxia Pharmaceuticals Inc. and Shattuck Labs, Inc. are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and Shattuck Labs, Inc. are of similar size ($450.6M and $429.1M). Across the 10 metrics below, Shattuck Labs, Inc. leads on 9 and Eupraxia Pharmaceuticals Inc. on 1.

Valuation

Metric EPRX STTK Biotechnology median
P/E n/m n/m 10.60
P/S n/m 106.26 9.40
P/B 4.52 2.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 69.10 9.02
Earnings yield (14.46%) (11.11%) (32.88%)
Free cash flow yield (8.45%) (6.92%) (23.13%)

Profitability

Metric EPRX STTK Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (117.82%) (39.21%) (51.96%)
Return on assets (64.44%) (36.88%) (46.06%)
Return on invested capital 0.00% (1,230.74%) 0.00%

Growth

Metric EPRX STTK Biotechnology median
Revenue growth (TTM) — 106.48% 6.76%
EPS growth (last fiscal year) (35.53%) 53.02% 29.88%
Revenue growth, 5-year CAGR — (36.82%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EPRX STTK Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 16.00 27.59 4.97
Net debt to EBITDA 2.11 1.62 1.01

Dividend

Metric EPRX STTK Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EPRX STTK Biotechnology median
Market cap 429.13m 450.63m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack